Narrative review examines metabolic syndrome and novel agents in kidney transplant recipients
Kidney transplant patients face high metabolic risks and rejection
This narrative review addresses antibody-mediated rejection and metabolic syndrome in kidney transplantation recipients. The authors note th…
About half of kidney transplant recipients develop metabolic problems within a year, while antibody-mediated rejection remains a major cause…
Review of alpha-gal syndrome highlights tick bite link and knowledge gaps
Tick bites may explain why some people develop alpha-gal allergy
This narrative review synthesizes evidence on alpha-gal syndrome, focusing on tick bites as a sensitizing exposure. The authors note that ep…
A review links tick bites to alpha-gal syndrome, though scientists still do not fully understand the biological mechanisms behind this react…
Systematic review and meta-analysis of resveratrol for spinal cord injury in animal models
Resveratrol shows promise for spinal cord injury in animal studies
This systematic review and meta-analysis of 38 preclinical animal studies found that resveratrol significantly improved locomotor recovery a…
A review of animal studies suggests resveratrol may improve movement and reduce damage after spinal cord injury, but human trials are needed…
Molecular review explores Siglec signaling pathways in cancer and inflammatory disorders
Siglec proteins help immune system balance fighting disease and avoiding self-harm
This molecular review examines the role of Siglec signaling pathways in human biology. The authors discuss potential therapeutic opportuniti…
Siglec proteins act as brakes on immune cells, and targeting them could help treat cancer and autoimmune disorders.
Narrative review highlights diagnostic gaps for house dust mite allergy in tropical regions
Understanding house dust mite allergy challenges in tropical regions for better patient care
This narrative review examines house dust mite allergy in populations living in tropical regions. The authors note that significant knowledg…
This review highlights how house dust mites cause allergies differently in tropical areas. Experts say current tools often miss these unique…
COPD guideline proposes cellular phenotype classification for targeted therapy
New framework shifts COPD care from symptom control to targeting disease drivers
This guideline review proposes classifying COPD by cellular phenotype to guide targeted therapies. It synthesizes evidence on neutrophilic, …
A new guideline offers a fresh way to treat chronic obstructive pulmonary disease by targeting specific disease drivers instead of just mana…
Living systematic review finds low-certainty evidence that stopping csDMARDs before surgery may increase flare risk in inflammatory arthritis
Stopping arthritis drugs before surgery may raise flare risk
This living systematic review evaluates perioperative management of conventional synthetic DMARDs in adults with rheumatoid arthritis, psori…
Low-certainty evidence suggests stopping certain arthritis drugs before surgery might increase the chance of a disease flare, but infection …
Meta-analysis of upadacitinib for rheumatoid arthritis finds similar efficacy for 15 mg and 30 mg doses
Upadacitinib improves rheumatoid arthritis symptoms in meta-analysis
This systematic review and meta-analysis of 5,237 participants with rheumatoid arthritis found that upadacitinib 15 mg and 30 mg significant…
A new analysis finds upadacitinib helps rheumatoid arthritis symptoms, but higher dose raises infection risk.
Narrative review discusses extracellular vesicles as biomarkers for cancer, neurological disorders, and cardiovascular diseases
Extracellular vesicles show promise as biomarkers for multiple diseases
This narrative review evaluates the potential of extracellular vesicles (EVs) as biomarkers for cancer, neurological disorders, and cardiova…
A review suggests extracellular vesicles could serve as useful biomarkers for cancer, neurological disorders, and cardiovascular diseases, t…
FDA Approves Fasenra (benralizumab) for Severe Eosinophilic Asthma and EGPA
FDA approves new drug Fasenra for severe asthma and rare disease.
FDA approved Fasenra (benralizumab) for add-on maintenance treatment of severe eosinophilic asthma in patients aged 6 years and older, and f…
The FDA approved Fasenra (benralizumab) for severe asthma in patients 6 and older, and for a rare condition called EGPA in adults. It works …
Commentary on plateau in lupus nephritis trials and path to precision medicine
New lupus drugs hit a ceiling where kidney healing stops improving
This commentary reviews 200 interventional pharmacological trials in lupus nephritis. The authors note a persistent ceiling effect with comp…
Kidney healing in lupus patients using new drugs often stops improving after reaching a 40 to 50 percent success rate, limiting how much bet…
Review of antiviral and immunotherapeutic strategies for chronic hepatitis B
New antiviral strategies show promise for chronic hepatitis B infection
This narrative review synthesizes evidence on antiviral and immunotherapeutic strategies for chronic hepatitis B. The authors highlight func…
A review of new treatments suggests combination therapies may offer future value for managing chronic hepatitis B, cirrhosis, and liver canc…